Rates of upper airway infections (UAIs) such as croup and bacterial tracheitis among pediatric COVID-19 patients, though low, rose after the Omicron variant became dominant in December 2021, with more than one fifth of hospitalized children with both conditions developing severe illness, estimates a study today in JAMA Pediatrics.
Depression and loneliness have increased among older adults during the pandemic, prompting a need for more coordinated efforts to address the issue, according to a report on social isolation in older Canadians.
Three new studies to be presented at the upcoming European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference at the end of the month demonstrate benefits of the antiviral molnupiravir against COVID-19 infections, including evidence that Merck's pill reduces symptoms of the SARS-CoV-2 virus by day 3 of administration.
A study this week in Clinical Infectious Diseases reveals high levels of childhood antibiotic exposure in low- and middle-income countries (LMICs).
Also, WHO experts say polio is still a global public health emergency.
The Centers for Disease Control and Prevention (CDC) said COVID-19 vaccine uptake among children 5 to 11 years old in the United States remained low during the first 11 weeks of vaccine eligibility, especially in high social vulnerability index (SVI) areas. The research was published today in Morbidity and Mortality Weekly Report (MMWR).
Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study yesterday in Open Forum Infectious Diseases.
Hospitalized COVID-19 patients with congenital heart defects (CHDs) were more likely to be admitted to an intensive care unit (ICU), require invasive mechanical ventilation (IMV), and die than those without CHDs in the first 11 months of the pandemic, suggests a study published today in Circulation.
The estimated effectiveness of the Pfizer/BioNTech COVID-19 vaccine against infection in US adolescents was 91%, with 93% protection against symptomatic illness and 85% against asymptomatic disease amid the Delta SARS-CoV-2 surge in Connecticut, finds a study published yesterday in JAMA Network Open.
More than 5 million children have lost a parent or caregiver during the COVID-19 pandemic, according to a modeling study published yesterday in The Lancet Child & Adolescent Health.
